Erratum: Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

被引：0
|
作者：
Wolfgang Gaebel
Andreas Schreiner
Paul Bergmans
Rosario de Arce
Frédéric Rouillon
Joachim Cordes
Lars Eriksson
Enrico Smeraldi
机构：
来源：
Neuropsychopharmacology | 2011年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Neuropsychopharmacology (2010) 35, 2367–2377; doi:10.1038/npp.2010.111; published online 4 August 2010 In this article, the authors would like to apologize for an error inadvertently introduced into the paper. During pre-marketing clinical studies, reactions that presented with signs and symptoms consistent with olanzapine overdose were reported in patients following an injection of olanzapine pamoate.
引用
收藏
页码：548 / 548
相关论文
共 50 条
  • [21] EFFICACY OF LONG-ACTING INJECTABLE RISPERIDONE IN DELUSIONAL DISORDER: AN OPEN-LABEL, NATURALISTIC AND PROSPECTIVE STUDY
    Gonzalez Rodriguez, A.
    Molina Andreu, O.
    Imaz Gurrutxaga, M. L.
    Pons Villanueva, A.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [22] Risperidone long-acting injectable for maintenance therapy in bipolar disorder:: An open-label pilot study
    Braeunig, Peter
    Sacchett, Emilio
    Medori, Rossella
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (01) : 74 - 77
  • [23] Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia A Randomized Clinical Trial
    Subotnik, Kenneth L.
    Casaus, Laurie R.
    Ventura, Joseph
    Luo, John S.
    Hellemann, Gerhard S.
    Gretchen-Doorly, Denise
    Marder, Stephen
    Nuechterlein, Keith H.
    JAMA PSYCHIATRY, 2015, 72 (08) : 822 - 829
  • [24] Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)
    de Arce Cordon, Rosario
    Eding, Evelin
    Marques-Teixeira, Joao
    Milanova, Vihra
    Rancans, Elmars
    Schreiner, Andreas
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2012, 262 (02) : 139 - 149
  • [25] DESCRIPTIVE ANALYSES OF THE ARIPIPRAZOLE ARM IN THE RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE RELAPSE PREVENTION TRIAL (CONSTATRE)
    de Arce, R.
    Eding, E.
    Marques-Teixeira, J.
    Milanova, V.
    Rancans, E.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [26] Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)
    Rosario de Arce Cordón
    Evelin Eding
    Joao Marques-Teixeira
    Vihra Milanova
    Elmars Rancans
    Andreas Schreiner
    European Archives of Psychiatry and Clinical Neuroscience, 2012, 262 : 139 - 149
  • [27] Risperidone vs haloperidol for relapse prevention in schizophrenia and schizoaffective disorder: A long-term double-blind comparison
    Csernansky, JG
    Okamoto, A
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 31S - 32S
  • [28] An open-label trial of risperidone long-acting injectable in the treatment of subject with recent onset psychosis
    Emsley, R.
    Schreiner, A.
    Koen, L.
    Oosthuizen, P.
    Niehaus, D.
    Rabinowitz, J.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A100 - A100
  • [29] Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
    Apostolos Aidonopoulos
    Anastasios Kanistras
    Anastasia Karastergiou
    Athanasios Karavatos
    Konstantinos Katsafouros
    Konstantinos Kontis
    Venetsanos Mavreas
    Maria Tzanakaki
    Nikolaos Tzavaras
    Errikos Tzebelikos
    Annals of General Psychiatry, 5 (Suppl 1)
  • [30] A descriptive, open-label, long-term follow-up survey of psychotic patients receiving risperidone long-acting injectable: Preliminary results
    Viala, Annie
    Cornic, Francoise
    Benamor, Cyrine
    Baldacci, Chantal
    Cheref, Smail
    Gauillard, Jacques
    Martin, Pascal
    Caroli, Francois
    Vacheron, Marie Noelle
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 (02) : 138 - 146
12345